ABIOMED

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Abiomed (ABMD) delivered earnings and revenue surprises of 4.17% and -2.61%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Abiomed (ABMD) Beats Q4 Earnings Estimates

Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Abiomed (ABMD) Q4 Earnings Expected to Decline

Arista Networks

Alphabet

Incyte

IPG Photonics

Intuitive Surgical

Regeneron Pharmaceuticals

Skyworks Solutions

Vertex Pharmaceuticals

Given the near-term economic uncertainty surrounding the COVID-19 outbreak, investors have been shifting their focus from growth stocks to stocks that have the balance sheets and liquidity to weather the current downturn.

10 Stocks To Buy With Low Debt And High Liquidity

Becton, Dickinson and Co.

Orthofix International

Amid the pandemonium on the account of coronavirus, we look into three stocks that have been struggling to cope with the scenario.

Coronavirus Hits Elective Procedures: 3 MedTech Stocks to Avoid

Mastercard

MarketAxess Holdings

NVIDIA

Constellation Brands

Ulta Beauty

United Rentals

From a list of the 20 best-performing S&P 500 stocks of the past decade, I’ve selected seven that I feel can deliver a repeat performance.  
The post These 7 S&P 500 Stocks Will Deliver a Repeat Performance in the Next Decade appeared first on InvestorPlace.

These 7 S&P 500 Stocks Will Deliver a Repeat Performance in the Next Decade

Integra LifeSciences Holdings

IART vs. ABMD: Which Stock Is the Better Value Option?

IART vs. ABMD: Which Stock Should Value Investors Buy Now?

Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock?

Abiomed (ABMD) Down 19.9% Since Last Earnings Report: Can It Rebound?

CenturyLink

General Electric

Thursday's big stock charts feature names with intriguing bull cases. All are looking for support in a market that hasn't yet found a bottom.

3 Big Stock Charts for Thursday: General Electric, Abiomed, and CenturyLink

The medical device maker's stock dropped 9%, then recovered.

Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed

Abiomed, Inc.'s (ABMD) CEO Michael Minogue on Q3 2020 Results- Earnings Call Transcript

Flagship Impella drives ABIOMED's (ABMD) fiscal third-quarter results; FY20 revenue guidance slashed.

ABIOMED (ABMD) Earnings Beat Estimates in Q3, Revenues Miss

Cardinal Health

10X Genomics

Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.

Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More

Flagship Impella likely to have boosted ABIOMED's (ABMD) fiscal Q3 earnings.

ABIOMED (ABMD) to Report Q3 Earnings: What's in the Offing?

ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.

ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View

Abiomed's sneak peek at its Q3 results leaves investors underwhelmed.

Why Abiomed Shares Are Sinking Today

Camping World Hlds

Marathon Petroleum

Viper Energy Partners LP

The four stocks that Wall Street analysts most adored a year ago all fell.

All 4 of Analysts’ Favorite Stocks Fell Last Year

ACADIA Pharma

Accelerate Diagnostics

DexCom

Exact Sciences

Jazz Pharmaceuticals

Neurocrine Biosciences

NeoGenomics

Repligen

Simulations Plus

The 10 Best Healthcare Stocks of the Decade

Align Technology

Amazon

Broadcom

Netflix

Old Dominion Freight Line

The 2010s was an exceptional decade on Wall Street no matter how you look at it. Not only was there no economic recession or bear market at any point in the decade, the S&P 500 nearly tripled throughout the 2010s, gaining 190% and making new all-time highs.

10 Best Performing S&P 500 Stocks Of The Decade

Advanced Micro Devices

Chipotle

DXC Technology

Gap Inc

KLA-Tencor

Lam Research

Macy's

Occidental Petroleum

Target

The S&P 500 Index has risen by more than 28% in 2019. Of the 10 most heavily weighted shares in the index, none was among the best or worst performers for the full year.

5 Top (and Bottom) Performers in 2019 Among the S&P 500

Robust demand for memory chips and other cutting-edge technology products are fueling growth in the space.

5 Best-Performing Technology Stocks of a Decade

Diamond Offshore Drilling Inc

Fossil Group

Macerich

Owens-Illinois

Southwestern Energy

TripAdvisor

The S&P 500 had another big year this year, gaining more than 28% year to date. Most U.S.

10 Worst Performing S&P 500 Stocks Of 2019

Adamas Pharmaceuticals

ANGI Homeservices

Kraft Heinz

PG&E

Pfizer

Walgreens

Despite a continuation of the stock market bull run, there were a bunch of underperformers this year, including Macy's, TripAdvisor and Abiomed.

10 Worst-Performing Stocks of 2019

Comcast

Disney

AT&T

Top Stocks Of The 2010s

An update from the FDA is easing fears about the medical device maker's primary product.

Good News From the FDA Should Fuel Abiomed’s Growth Into the Future

A. O. Smith

DuPont de Nemours

Dell Technologies

Foot Locker

Hess

Kohl's

MasTec

PagSeguro Digital

Rollins

2019 has been one of the best years for stocks in recent memory. Heading into 2020, here are 10 stocks to buy that are struggling to finish well.

10 Stocks to Buy That Lost 8%-Plus in the Past Month

News for ABIOMED Stock (ABMD)